BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease
The primary objective of this study is to enhance the rates of direct breast feeding
(DBF) among infants with congenital heart disease (CHD), and to gain insights into the
implications of DBF on key metrics of child and parent well-being. A multicenter parallel
clust...
Age: 18 years - 66+
Gender: All
Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)
This is a two-arm, prospective, longitudinal, randomized controlled trial (RCT) that will
compare usual care to usual care plus a prenatally initiated, virtually administered
psychological intervention, called HeartGPS.
Age: 18 years - 66+
Gender: All
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
This real-world, international registry aims to evaluate the current experience with
sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease
(ACHD) patients by investigating the prescription patterns, safety, tolerability, and
potential b...
Age: 18 years - 66+
Gender: All
Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)
Recent retrospective studies have demonstrated differences between pulse oximeter values
(SpO2) and measured arterial oxygen saturation (SaO2) in patients identifying as Black or
Hispanic. These retrospective studies have limitations because self-reported race is
lik...
Age: Birth - 18 years
Gender: All
ALTERRA Post-Approval Study
This study will monitor device performance and outcomes in subjects undergoing
implantation of the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra
Adaptive Prestent in the post-approval setting
Age: Birth - 66+
Gender: All
MINDS Imaging Ancillary Study
This study is an ancillary study to the NHLBI-funded Pediatric Heart Network (PHN)
"Multi-Institutional Neurocognitive Discovery Study" (MINDS) in Adult Congenital Heart
Disease (ACHD). The MINDS-ACHD" study will recruit 500 complex CHD patients between18-30
years...
Age: 18 - 30 years
Gender: All
Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II
This is an international, cross-sectional and descriptive study that aims to investigate differences in patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) and that aims to explore the profile and healthcare needs of adults with co...
Age: 18 years - 66+
Gender: All
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Congenital heart defects (CHD) are the most common major human birth malformation,
affecting ~8 per 1,000 live births. CHD are associated with significant morbidity and
mortality, and are second only to infectious diseases in contributing to the infant
mortality rate...
Age: Birth - 99 years
Gender: All